My BCR ABL app for iPhone and iPad

This App has been created by Novartis Pharmaceuticals Australia Pty Limited ACN 004 244 160 (Novartis) as a resource to assist patients with Chronic Myeloid Leukaemia (CML) who have been prescribed Tasigna®. The application requires a password which can be obtained from the patient’s healthcare professional.
Disclaimer: This App is not a medical device and is intended for an Australian Audience. This App is intended for use as a personal tool only. This App, and the information generated by it, is not intended for as a basis for any diagnosis, monitoring, management or treatment of CML or any other medical condition. It is intended solely for personal use.
It is not intended to, and does not provide a means for users to self-diagnose any medical condition nor is intended to guide any decision to treat a medical condition. Users of this App who have any health concerns or medical problems should consult with a qualified healthcare professional. Novartis does not guarantee the security of any information stored in this application or in your device or transmitted from the application. You are responsible for any information that you store in your application or transmit from the application or from your device.
This App is published by Novartis Pharmaceuticals Australia Pty Ltd, 56 Waterloo Rd, Macquarie Park 2113, TAS0746, December 2015